Cercar
01/10/2024
FRAILTY SYNDROME IN ADULTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION. PROSPECTIVE STUDY ON BEHALF OF THE GRUPO ESPANOL DE TRASPLANTE HEMATOPOYETICO Y TERAPIA CELULAR (GETH-CT)
Salas, MQ, Solano, MT, Baile-Gonzalez, M, Acera-G mez, M, Fox, L, Perez-Artigas, MD, Santamar a, A, Quintela-Gonz lez, MD, S nchez-Salinas, A, Salmer n-Camacho, JM, Illana-Alvaro, V, Abdallahi-Lefdil, Z, Cornago-Navascues, J, Pardo, L, Fern ndez-Luis, S, Vega-Su rez, LP, Villar, S, Beorlegui-Murillo, P, Esquirol, A, Izquierdo-Garc a, I, Rodr guez-Gonz lez, S, Mussetti, A, Abuin-Blanco, A, Lopez-Mar n, J, Filarerro, S, Bento, L, Sureda, A. FRAILTY SYNDROME IN ADULTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION. PROSPECTIVE STUDY ON BEHALF OF THE GRUPO ESPANOL DE TRASPLANTE HEMATOPOYETICO Y TERAPIA CELULAR (GETH-CT). BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/09/2024
Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study
Bobes, A, Tormo, M, Diaz-Beya, M, Beneit, P, Botella, C, Moreno, AF, Mayol, AS, Sangerman, MA, Bermejo, AY, Amigo, MD, Labrador, J, Guinon, AG, Garrido, A, Serrano, J, Polo, SV, Fortes, MG, Sayas, MJ, Bergua, JM, Olave, MT, Vall-Llovera, F, Bargay, J, Sanchez, MP, Boyero, RG, Diaz-Lopez, A, de la Fuente, A. Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study. Clinical Lymphoma Myeloma & Leukemia. 2024; 24DOI:. PMID:. IF:2.700(Q2/4D).
13/08/2024
PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT
Montoro, J, Ngoya, M, Kulagin, A, Giebel, S, Broers, AEC, Bramanti, S, Halahleh, K, Pérez-Simón, JA, Solano, C, Ozcelik, T, Blaise, D, Sanz, J, Henriques, M, de Latour, RP, Martino, R, Scheid, C, Fox, L, Gromek, T, Jurado, M, Sakellari, I, Van Gorkom, G, Matteucci, P, Nagler, A, Koc, Y, Glass, B. PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT. Blood Advances. 2024; 8(15)DOI:10.1182/bloodadvances.2024013328. PMID:38810260. IF:7.100(Q1/2D).
01/01/2022
Risk factors analysis according to regional distribution of white matter hyperintensities in a stroke cohort
Medrano-Martorell, S, Capellades, J, Jimenez-Conde, J, Gonzalez-Ortiz, S, Vilas-Gonzalez, M, Rodriguez-Campello, A, Ois, A, Cuadrado-Godia, E, Avellaneda, C, Fernandez, I, Merino-Pena, E, Roquer, J, Marti-Fabregas, J, Giralt-Steinhauer, E. Risk factors analysis according to regional distribution of white matter hyperintensities in a stroke cohort. EUROPEAN RADIOLOGY. 2022; 32(1)DOI:10.1007/s00330-021-08106-2. PMID:34117555. IF:5.900(Q1/2D).